LOL, but no one is interested in buying NWBO. LP has been bending over backwards and diluting in pennies for years. They all ran as fast and far away as possible, particularly after May 2022 fiasco.
No big pharma will touch it at even 0.10. Too much credibility risk and overhead for little to no commercial value. That’s why LP continues to dilute in pennies with shady financiers squeezing her both ways. Too bad she can’t even get to JP Morgan Healthcare conference to build awareness about NWBO. Or maybe she gave up because she knows no savvy folks would listen. So just continue pump and dump cycles and keep shady financiers happy! ;)
Market Data 
Markets 
AI
